Drug profile · INN
ombitasvir
VIEKIRAX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ombitasvir (VIEKIRAX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ombitasvir
Brand VIEKIRAX
Route ORAL
Formulation TABLET
ATC code J05AP53
Frequently asked questions
What is ombitasvir?
ombitasvir (VIEKIRAX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ombitasvir?
VIEKIRAX is a marketed brand name for ombitasvir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ombitasvir?
ombitasvir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.